Episodic Cost of Lower Respiratory Tract Illness due to Respiratory Syncytial Virus Among US Infants During the First Year of Life

被引:1
|
作者
Averin, Ahuva [1 ]
Law, Amy [2 ]
Shea, Kimberly [2 ]
Atwood, Mark [1 ]
Munjal, Iona [2 ]
Weycker, Derek [1 ]
机构
[1] Policy Anal Inc, 116 Huntington Ave,Suite 903, Boston, MA 02116 USA
[2] Pfizer Inc, Collegeville, PA USA
关键词
costs and cost analysis; infant; respiratory syncytial viruses; respiratory tract infections; HEALTH-CARE COSTS; FULL-TERM; INFECTION; PRETERM; HOSPITALIZATION;
D O I
10.1093/infdis/jiad598
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A study of 2 health care claims databases (commercial, Medicaid) was undertaken to estimate the episodic cost of lower respiratory tract illness due to respiratory syncytial virus among infants aged <12 months overall, by age, and by birth gestational age. Among commercial-insured infants, mean costs were $28 812 for hospitalized episodes, $2575 for emergency department episodes, and $336 for outpatient clinic episodes. Costs were highest among infants aged <1 month and infants with a gestational age <= 32 weeks and were comparable among Medicaid-insured infants, albeit somewhat lower. The cost of lower respiratory tract illness due to respiratory syncytial virus during the acute phase of illness is high, especially among the youngest infants and those born premature.
引用
收藏
页码:480 / 484
页数:5
相关论文
共 50 条
  • [41] Clinical characteristics and risk factors of severe respiratory syncytial virus-associated acute lower respiratory tract infections in hospitalized infants
    Zhang, Xiao-Bo
    Liu, Li-Juan
    Qian, Li-Ling
    Jiang, Gao-Li
    Wang, Chuan-Kai
    Jia, Phi
    Shi, Peng
    Xu, Jin
    Wang, Li-Bo
    WORLD JOURNAL OF PEDIATRICS, 2014, 10 (04) : 360 - 364
  • [42] Clinical characteristics and risk factors of severe respiratory syncytial virus-associated acute lower respiratory tract infections in hospitalized infants
    Xiao-Bo Zhang
    Li-Juan Liu
    Li-Ling Qian
    Gao-Li Jiang
    Chuan-Kai Wang
    Pin Jia
    Peng Shi
    Jin Xu
    Li-Bo Wang
    World Journal of Pediatrics, 2014, 10 : 360 - 364
  • [43] Chronologic Age at Hospitalization for Respiratory Syncytial Virus Among Preterm and Term Infants in the United States
    Rohan C. Parikh
    Kimmie K. McLaurin
    Andrea V. Margulis
    Josephine Mauskopf
    Christopher S. Ambrose
    Melissa Pavilack
    Sean D. Candrilli
    Infectious Diseases and Therapy, 2017, 6 : 477 - 486
  • [44] Significance of total serum IgE in children with lower respiratory infections due to respiratory syncytial virus
    Jang, Yoon Young
    Lee, Hyun Seok
    Jeong, Ji Eun
    Hong, Suk Jin
    Park, Hye Jin
    Lee, Kye Hyang
    Kim, Wootaek
    Chung, Hai Lee
    ALLERGY ASTHMA & RESPIRATORY DISEASE, 2016, 4 (02): : 126 - 132
  • [45] Epidemiology of respiratory syncytial virus in a community birth cohort of infants in the first 2 years of life
    Mari D. Takashima
    Keith Grimwood
    Peter D. Sly
    Stephen B. Lambert
    Keith J. Chappell
    Daniel Watterson
    Robert S. Ware
    European Journal of Pediatrics, 2021, 180 : 2125 - 2135
  • [46] Epidemiology of respiratory syncytial virus in a community birth cohort of infants in the first 2 years of life
    Takashima, Mari D.
    Grimwood, Keith
    Sly, Peter D.
    Lambert, Stephen B.
    Chappell, Keith J.
    Watterson, Daniel
    Ware, Robert S.
    EUROPEAN JOURNAL OF PEDIATRICS, 2021, 180 (07) : 2125 - 2135
  • [47] Healthcare Providers' and Pregnant People's Preferences for a Preventive to Protect Infants from Serious Illness Due to Respiratory Syncytial Virus
    Beusterien, Kathleen M.
    Law, Amy W.
    Maculaitis, Martine C.
    Will, Oliver
    Kopenhafer, Lewis
    Olsen, Patrick
    Hauber, Brett
    Vietri, Jeffrey T.
    Cappelleri, Joseph C.
    Coulter, Joshua R.
    Shea, Kimberly M.
    VACCINES, 2024, 12 (05)
  • [48] Respiratory Syncytial Virus (RSV) Neutralizing Antibodies at Birth Predict Protection from RSV Illness in Infants in the First 3 Months of Life
    Buchwald, Andrea G.
    Graham, Barney S.
    Traore, Awa
    Haidara, Fadima Cheick
    Chen, Man
    Morabito, Kaitlyn
    Lin, Bob C.
    Sow, Samba O.
    Levine, Myron M.
    Pasetti, Marcela F.
    Tapia, Milagritos D.
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (11) : E4421 - E4427
  • [49] SENTINEL1: An Observational Study of Respiratory Syncytial Virus Hospitalizations among US Infants Born at 29 to 35 Weeks' Gestational Age Not Receiving Immunoprophylaxis
    Anderson, Evan J.
    Krilov, Leonard R.
    DeVincenzo, John P.
    Checchia, Paul A.
    Halasa, Natasha
    Simoes, Eric A. F.
    Domachowske, Joseph B.
    Forbes, Michael L.
    Pannaraj, Pia S.
    McBride, Scott J.
    McLaurin, Kimmie K.
    Kumar, Veena R.
    Ambrose, Christopher S.
    AMERICAN JOURNAL OF PERINATOLOGY, 2017, 34 (01) : 51 - 61
  • [50] The full value of immunisation against respiratory syncytial virus for infants younger than 1 year: effects beyond prevention of acute respiratory illness
    Feikin, Daniel R.
    Karron, Ruth A.
    Saha, Samir K.
    Sparrow, Erin
    Srikantiah, Padmini
    Weinberger, Daniel M.
    Zar, Heather J.
    LANCET INFECTIOUS DISEASES, 2024, 24 (05) : e318 - e327